Insider Trading & Ownership - Cline Darren S

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Cline Darren S
Common stock purchase or sale:
Transaction
Date		Reported
DateTime		CompanySymbolInsider
Relationship		Shares
Traded		Average
Price		Total
Amount		Shares
Owned		Filing
2021-12-08
Purchase		2021-12-09
4:18 pm		Pyxis Oncology Inc.PYXSCline Darren S
Director		10,000$9.3885$93,88510,000
(Direct)		View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		Reported
DateTime		Exercisable
Expiration		CompanySymnbolInsider
Relationship		Shares
Traded		Conversion
Price		Shares
Owned		Filing
2024-03-26
Option Award		2024-03-28
4:33 pm		N/A
N/A		Pyxis Oncology Inc.PYXSCline Darren S
Director		35,219$0251,405
(Direct)		View
2023-06-16
Option Award		2023-06-20
6:41 pm		N/A
2033-06-15		IMPEL PHARMACEUTICALS INCIMPLCline Darren S
Director		13,222$013,222
(Direct)		View
2023-06-07
Option Award		2023-06-08
5:09 pm		N/A
2033-06-07		PLIANT THERAPEUTICS INC.PLRXCline Darren S
Director		14,000$014,000
(Direct)		View
2023-04-12
Option Award		2023-04-14
4:58 pm		N/A
2033-04-11		IMPEL PHARMACEUTICALS INCIMPLCline Darren S
Director		20,013$020,013
(Direct)		View

Ownership		2023-04-13
6:10 pm		N/A
N/A		IMPEL PHARMACEUTICALS INCIMPLCline Darren S
Director		0$00
(Direct)		View
2023-03-24
Option Award		2023-03-28
4:41 pm		N/A
N/A		Pyxis Oncology Inc.PYXSCline Darren S
Director		139,355$0216,186
(Direct)		View
2023-03-06
Option Award		2023-03-08
4:36 pm		N/A
2033-03-06		PLIANT THERAPEUTICS INC.PLRXCline Darren S
Director		22,000$022,000
(Direct)		View
2022-03-31
Option Award		2022-04-04
4:15 pm		N/A
N/A		Pyxis Oncology Inc.PYXSCline Darren S
Director		66,831$076,831
(Direct)		View
2021-10-07
Option Award		2021-10-12
7:47 pm		N/A
2031-10-07		Pyxis Oncology Inc.PYXSCline Darren S
Director		42,191$042,191
(Direct)		View

Ownership		2021-10-07
9:10 pm		N/A
2031-08-18		Pyxis Oncology Inc.PYXSCline Darren S
Director		0$015,725
(Direct)		View
2021-05-05
Disposition		2021-05-07
4:21 pm		N/A
2029-05-28		GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer		585,276$00
(Direct)		View
2021-03-02
Option Award		2021-03-04
9:05 pm		N/A
N/A		GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer		121,920$0121,920
(Direct)		View
2021-02-22
Option Award		2021-02-24
6:53 pm		N/A
N/A		GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer		121,920$0121,920
(Direct)		View
2020-06-10
Equity Swap		2020-06-10
11:15 am		N/A
N/A		STEMLINE THERAPEUTICS INCSTMLCline Darren S
Director		35,468$00
(Direct)		View
2020-06-04
Option Award		2020-06-08
8:00 pm		N/A
N/A		GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer		283,500$0283,500
(Direct)		View
2020-05-28
Exercise		2020-05-29
8:00 pm		N/A
N/A		GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer		7,356$0.00125,556
(Direct)		View
2020-05-28
Exercise		2020-05-29
8:00 pm		2020-05-28
2020-05-28		GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer		7,356$05,556
(Direct)		View
2020-05-28
Tax Withholding		2020-05-29
8:00 pm		N/A
N/A		GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer		1,800$10.545,556
(Direct)		View
2019-06-25
Option Award		2019-06-28
5:15 pm		N/A
N/A		STEMLINE THERAPEUTICS INCSTMLCline Darren S
Director		15,000$035,468
(Direct)		View
2019-05-28
Option Award		2019-05-30
8:00 pm		2022-05-28
2029-05-28		GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer		152,232$0181,656
(Direct)		View
2019-05-28
Option Award		2019-05-30
8:00 pm		N/A
N/A		GW PHARMACEUTICALS PLCGWPHCline Darren S
U.S. Chief Commercial Officer		29,424$0.0013181,656
(Direct)		View